Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000248324 | SCV000316362 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000005670 | SCV000450252 | benign | Ellis-van Creveld syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Gene |
RCV000248324 | SCV000517136 | benign | not specified | 2016-05-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV001573446 | SCV000603489 | benign | not provided | 2023-10-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000527342 | SCV000634715 | benign | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000248324 | SCV000703547 | benign | not specified | 2017-01-11 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000987404 | SCV001136693 | benign | Curry-Hall syndrome | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000005670 | SCV001737235 | benign | Ellis-van Creveld syndrome | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001573446 | SCV005297761 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000005670 | SCV000025852 | uncertain significance | Ellis-van Creveld syndrome | 2000-03-01 | no assertion criteria provided | literature only | |
Natera, |
RCV000005670 | SCV001452192 | benign | Ellis-van Creveld syndrome | 2019-09-12 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000248324 | SCV001742150 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001573446 | SCV001799350 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000248324 | SCV001928880 | benign | not specified | no assertion criteria provided | clinical testing |